EMA
approval
· 2023-07-21
First RSV vaccine to protect infants up to 6 months of age and older adults
Summary
EMA announces the first RSV vaccine that can protect infants up to 6 months of age and older adults, marking a pivotal approval for RSV prevention across these …
Upgrade for the full analysis, importance score, and drug timeline.